𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interim results of a pilot study demonstrating the early effects of the PPAR-γ ligand rosiglitazone on insulin sensitivity, aminotransferases, hepatic steatosis and body weight in patients with non-alcoholic steatohepatitis

✍ Scribed by Brent A. Neuschwander-Tetri; Elizabeth M. Brunt; Kent R. Wehmeier; Craig A. Sponseller; Karen Hampton; Bruce R. Bacon


Book ID
118565927
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
188 KB
Volume
38
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.